Press release
Cutaneous Squamous Cell Carcinoma (cSCC) Market Intelligence Report Covers Trends, Segments And Regional Growth
Cutaneous Squamous Cell Carcinoma (cSCC) Market
Projected Growth and Market Size of the Cutaneous Squamous Cell Carcinoma Market
The cutaneous squamous cell carcinoma market is forecasted to expand markedly, reaching a valuation of $10.35 billion by 2030. This growth represents a compound annual growth rate (CAGR) of 5.6% over the forecast period. Several factors contribute to this upward trend, including progress in skin cancer diagnostics, broader utilization of outpatient procedures, growth in dermatologic oncology centers, enhanced early detection accessibility, and breakthroughs in targeted therapy development. Key market trends include the increasing use of Mohs micrographic surgery, wider adoption of non-surgical treatments, growth in early skin cancer screening programs, expansion of outpatient cancer care, and a focus on minimally invasive interventions.
The cutaneous squamous cell carcinoma (cscc) market size has grown strongly in recent years. It will grow from $7.87 billion in 2025 to $8.33 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to high uv exposure rates, aging population growth, increased skin cancer awareness, reliance on surgical excision, hospital-based oncology care.
Download a free sample of the cutaneous squamous cell carcinoma (cscc) market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21163&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Leading Companies Influencing the Cutaneous Squamous Cell Carcinoma Market
The cSCC market features a number of prominent companies driving innovation and market share. Key players encompass F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GSK plc, Eli Lilly and Company, Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Incyte Corporation, Shanghai Henlius Biotech Inc., Fortress Biotech Inc., Rakuten Medical Inc., Morphogenesis Inc., Vidac Pharma Inc., Pfizer Inc., AstraZeneca plc, AbbVie Inc., Johnson & Johnson, Bayer AG, LEO Pharma A/S, and Sun Pharmaceutical Industries Ltd.
An important market development occurred in March 2025 when India-based Sun Pharmaceutical Industries Limited acquired Checkpoint Therapeutics, Inc. for about USD 355 million. This acquisition allows Sun Pharma to incorporate Checkpoint's FDA-approved anti-PD-L1 therapy Cosibelimab, targeting advanced cutaneous squamous cell carcinoma, thereby boosting its oncology portfolio and expanding global commercial reach. Checkpoint Therapeutics, headquartered in the United States, specializes in immunotherapy and targeted oncology treatments, with expertise in next-generation immune checkpoint inhibitors.
View the full cutaneous squamous cell carcinoma (cscc) market report:
https://www.thebusinessresearchcompany.com/report/cutaneous-squamous-cell-carcinoma-cscc-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Positive Market Trends Driving Growth in the Cutaneous Squamous Cell Carcinoma Sector
The cSCC market is seeing a strong focus on immuno-oncology innovations, particularly PD-L1 inhibitors and targeted therapies, which are designed to improve outcomes for patients with advanced skin cancer. PD-L1, or programmed death-ligand 1, is a protein that diminishes immune response by binding to PD-1 receptors on T-cells, allowing cancer cells to evade immune detection. A notable milestone was reached in December 2024 when Checkpoint Therapeutics received FDA approval for Unloxcyt (cosibelimab-ipdl), a therapy that blocks PD-L1 to enhance the immune system's ability to combat cancer. This treatment offers a safer and more effective option for advanced cSCC, employing dual mechanisms to target the disease. The approval was supported by data from the CK-301-101 clinical trial, which showed meaningful objective response rates and durable results in advanced cSCC patients.
Breakdown of the Cutaneous Squamous Cell Carcinoma Market by Treatment, Diagnosis, and Application
The market is segmented into several key categories to provide clarity on treatment options, diagnostic methods, and application areas. By treatment type, the market includes surgical and non-surgical therapies. Diagnostic methods cover computed tomography (CT), magnetic resonance imaging (MRI), and biopsy procedures. Application-wise, the market serves hospitals, cancer institutes, ambulatory surgical centers, and other healthcare settings.
Within surgical treatments, subcategories include excisional surgery, Mohs micrographic surgery, and curettage with electrodessication. Non-surgical treatments are further divided into radiation therapy, cryotherapy, photodynamic therapy, topical therapies, and systemic therapies, illustrating the diverse therapeutic approaches available for managing cutaneous squamous cell carcinoma.
Key enhancements in our 2026 market reports include:
• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cutaneous Squamous Cell Carcinoma (cSCC) Market Intelligence Report Covers Trends, Segments And Regional Growth here
News-ID: 4605550 • Views: …
More Releases from The Business Research Company
Deep Learning In Drug Discovery And Diagnostics Market Research Explores Growth …
The deep learning sector within drug discovery and diagnostics is rapidly evolving, driven by innovations that promise to transform healthcare. As artificial intelligence technologies become increasingly integrated into life sciences, the market is set to experience remarkable growth. Below, we explore the current market valuation, key players, emerging trends, and detailed segmentation to provide a comprehensive overview of this dynamic field.
Market Valuation Outlook for Deep Learning in Drug Discovery and…
Decentralized Trial Wearable Market Analysis Highlights Growth To $6.18 Billion …
The decentralized trial wearable industry is set to undergo remarkable expansion over the coming years, driven by technological advancements and evolving clinical research needs. This sector is increasingly attracting attention due to its potential to transform how clinical trials are conducted by enhancing remote patient monitoring and data accuracy. Let's explore the market's current outlook, key players, emerging trends, and the segments shaping its future trajectory.
Forecasted Market Value and Growth…
Da Vinci Systems Market Study Highlights How Industry Demand Is Evolving
The market for da Vinci surgical systems is poised for significant expansion in the coming years, driven by technological breakthroughs and growing acceptance of robotic-assisted procedures. With healthcare providers increasingly embracing minimally invasive surgery, this sector is set to transform surgical practices globally. Let's delve into the market size projections, leading companies, emerging innovations, and key segments shaping the future of da Vinci systems.
Forecasting the Growth Trajectory of the da…
Cyclic Heavy Menstrual Bleeding Market Research Reveals Strong 6.6% CAGR Outlook …
The cyclic heavy menstrual bleeding market is positioned for notable expansion in the coming years, driven by advancements in treatment options and growing awareness about women's reproductive health. As innovations continue to emerge, the market is set to evolve and provide better care solutions for patients experiencing this condition.
Market Size Expectations and Growth Drivers in the Cyclic Heavy Menstrual Bleeding Market
The cyclic heavy menstrual bleeding market is forecast…
More Releases for Cutaneous
Cutaneous Lupus Erythematosus (CLE) Market
Introduction
Cutaneous Lupus Erythematosus (CLE) is a chronic autoimmune skin disorder, often associated with systemic lupus erythematosus (SLE), that presents as inflammation, rashes, and photosensitivity. While CLE is rarely fatal, it significantly affects patients' physical and emotional well-being, often leading to scarring, disfigurement, and social stigma.
Over the past decade, the market for CLE therapies has gained global importance as research into autoimmunity has accelerated and biologic therapies have transformed dermatology. Rising…
Cutaneous Angiosarcoma Market New Product Development & Latest Trends
Introduction
Cutaneous angiosarcoma is a rare and aggressive malignancy that originates from endothelial cells lining blood vessels and lymphatics in the skin. Though it represents a small fraction of soft-tissue sarcomas, its high recurrence rates, metastatic potential, and poor prognosis make it one of the most challenging cancers to manage. The condition most frequently affects elderly patients and is often associated with chronic lymphedema, prior radiation exposure, or immunosuppression.
Traditional management has…
Emerging Trends Influencing The Growth Of The Cutaneous T-Cell Lymphoma Market: …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
How Big Is the Cutaneous T-Cell Lymphoma Market Size Expected to Be by 2034?
The market for cutaneous T-cell lymphoma has witnessed substantial growth in the past few years. It is projected to rise from a size of $2.54 billion in 2024 to $2.72 billion in 2025, equating to a compound annual…
Prominent Cutaneous Lupus Erythematosus Market Trend for 2025: Advancements In C …
What combination of drivers is leading to accelerated growth in the cutaneous lupus erythematosus market?
The rising prevalence of skin infections is expected to drive the growth of the cutaneous lupus erythematosus (CLE) market. Skin infections are caused by microorganisms that invade the skin, triggering immune responses that can worsen symptoms in individuals with CLE. For example, the UK saw a 33.7% increase in MRSA cases caused by skin and soft…
Key Trend Reshaping the Cutaneous Lupus Erythematosus Market in 2025: Advancemen …
What Are the Projections for the Size and Growth Rate of the Cutaneous Lupus Erythematosus Market?
The market size for cutaneous lupus erythematosus has seen quick expansion in the past few years. The growth is estimated to move from $2.24 billion in 2024 to $2.51 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 12.0%. This considerable increase in the historic period is a result of factors such as…
Cutaneous Lupus Erythematosus Market Trends & Analysis Report 2024
"The Business Research Company recently released a comprehensive report on the Global Cutaneous Lupus Erythematosus Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive…
